Get started

Financials · MOH

Molina Healthcare Inc (MOH) financials

For the twelve months ended Sep 30, 2026, Molina Healthcare Inc reported $44.13B of revenue and -$48.00M of net income.

Revenue, TTM
$44.13B
Revenue growth, YoY
-0.9%
Net income, TTM
-$48.00M
Net margin
-0.1%
Free cash flow, TTM
$236.00M
EPS, diluted, TTM
-$0.60
Cash
$4.48B
Total debt
$3.77B
P/S
0.24
Market cap
$10.61B
Annual revenue$45.43B
FY2016FY2025
Annual net income$472.00M
FY2016FY2025
Annual free cash flow-$636.00M
FY2016FY2025

MOH revenue and earnings growth

MOH revenueQ3 2026$11.08B

Quarter YoY
-3.4%
QoQ
+1.9%
FY YoY
+11.7%
5Y CAGR
+18.5%
10Y CAGR
+12.3%

MOH revenue was $11.08B in fiscal Q3 2026 (ended Sep 30, 2026), down 3.4% from a year earlier and up 1.9% from the prior quarter. For the full fiscal 2025 it was $45.43B, up 11.7% from fiscal 2024. Compound annual growth was +18.5% over 5 years and +12.3% over 10 years. It rose in 8 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

MOH net incomeQ3 2026$38.00M

Quarter YoY
-51.9%
QoQ
-36.7%
FY YoY
-60.0%
5Y CAGR
-6.8%
10Y CAGR
+12.7%

MOH net income was $38.00M in fiscal Q3 2026 (ended Sep 30, 2026), down 51.9% from a year earlier and down 36.7% from the prior quarter. For the full fiscal 2025 it was $472.00M, down 60.0% from fiscal 2024. Compound annual growth was -6.8% over 5 years and +12.7% over 10 years. It rose in 4 of the last 7 fiscal years.

MOH EPSQ3 2026$0.73

Quarter YoY
-51.7%
QoQ
-38.7%
FY YoY
-56.3%
5Y CAGR
-4.5%
10Y CAGR
+13.2%

MOH diluted EPS was $0.73 in fiscal Q3 2026 (ended Sep 30, 2026), down 51.7% from a year earlier and down 38.7% from the prior quarter. For the full fiscal 2025 it was $8.92, down 56.3% from fiscal 2024. Compound annual growth was -4.5% over 5 years and +13.2% over 10 years.

MOH free cash flowQ3 2026-$196.00M

MOH free cash flow was -$196.00M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$163.00M a year earlier. For the full fiscal 2025 it was -$636.00M, compared with $544.00M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue$45.43B$40.65B$34.07B$31.97B$27.77B$19.42B$16.83B$18.89B$19.88B$17.78B
Cost of revenue$39.49B$34.43B$28.67B$27.18B$23.70B$15.82B$13.90B---
Gross profit-----$2.48B$2.30B$2.52B$1.81B$1.73B
Selling, general and admin$3.01B$2.74B$2.46B$2.31B$2.07B$1.48B$1.30B$1.33B$1.59B$1.39B
Operating income$781.00M$1.71B$1.57B$1.17B$1.02B$1.08B$1.04B$1.13B-$555.00M$306.00M
Interest expense$192.00M$118.00M$109.00M$110.00M$120.00M$102.00M$87.00M$115.00M$118.00M$101.00M
Pre-tax income$589.00M$1.59B$1.46B$1.06B$875.00M$961.00M$972.00M$999.00M-$612.00M$205.00M
Income tax$117.00M$410.00M$373.00M$271.00M$216.00M$288.00M$235.00M$292.00M-$100.00M$153.00M
Net income$472.00M$1.18B$1.09B$792.00M$659.00M$673.00M$737.00M$707.00M-$512.00M$52.00M
EPS, basic$8.93$20.52$18.91$13.72$11.40$11.40$11.85$11.57-$9.07$0.93
EPS, diluted$8.92$20.42$18.77$13.55$11.25$11.23$11.47$10.61-$9.07$0.92
Diluted shares52.9M57.7M58.1M58.5M58.6M59.9M64.2M66.6M56.4M56.2M

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Cash and equivalents$4.25B$4.74B$4.85B$4.05B$4.51B$4.22B$2.51B$2.93B$3.29B$2.91B
Short-term investments$4.01B$4.33B$4.26B$3.50B$3.20B$1.88B$1.95B$1.68B$2.52B$1.76B
Receivables$3.53B$3.30B$3.10B$2.30B$2.18B$1.67B$1.41B$1.33B$871.00M$974.00M
Current assets$12.44B$12.77B$12.54B$10.08B$10.06B$7.88B$5.97B$6.46B$7.51B$5.99B
Goodwill$1.96B$1.67B$1.24B$1.11B$982.00M$692.00M$143.00M$143.00M$186.00M$620.00M
Total assets$15.56B$15.63B$14.89B$12.31B$12.21B$9.53B$6.79B$7.15B$8.47B$7.45B
Current liabilities$7.37B$7.90B$8.17B$6.86B$7.05B$4.96B$3.27B$4.25B$5.56B$4.57B
Short-term debt-----$0$18.00M--$472.00M
Long-term debt$3.77B$2.92B$2.18B$2.18B$2.17B$2.13B$1.24B$1.02B$1.32B$975.00M
Total debt$3.77B$2.92B$2.18B$2.18B$2.17B$2.13B$1.25B$1.02B$1.32B$1.45B
Total liabilities$11.49B$11.13B$10.68B$9.35B$9.58B$7.44B$4.83B$5.51B$7.13B$5.80B
Shareholders' equity$4.07B$4.50B$4.21B$2.96B$2.63B$2.10B$1.96B$1.65B$1.34B$1.65B

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Operating cash flow-$535.00M$644.00M$1.66B$773.00M$2.12B$1.90B$434.00M-$314.00M$804.00M$673.00M
Capital expenditures$101.00M$100.00M$84.00M$91.00M$77.00M$74.00M$57.00M$30.00M$86.00M$176.00M
Free cash flow-$636.00M$544.00M$1.58B$682.00M$2.04B$1.82B$377.00M-$344.00M$718.00M$497.00M
Investing cash flow$312.00M-$464.00M-$744.00M-$790.00M-$1.65B-$400.00M-$293.00M$1.14B-$1.06B-$206.00M
Financing cash flow-$170.00M-$347.00M-$58.00M-$441.00M-$183.00M$217.00M-$559.00M-$1.19B$636.00M$19.00M
Share repurchases$1.00B$1.00B$0$400.00M$128.00M$606.00M$47.00M$0$0-
Stock-based compensation$47.00M$116.00M$115.00M$103.00M$72.00M$57.00M$39.00M$27.00M$46.00M$26.00M
Depreciation and amortization$195.00M$186.00M$171.00M$176.00M$131.00M$88.00M$89.00M$127.00M$178.00M$182.00M

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue growth, YoY11.7%19.3%6.6%15.1%43.0%15.4%-10.9%-5.0%11.8%25.4%
Net income growth, YoY-60.0%8.1%37.8%20.2%-2.1%-8.7%4.2%---63.6%
EPS growth, YoY-56.3%8.8%38.5%20.4%0.2%-2.1%8.1%---64.3%
Gross margin-----12.8%13.7%13.3%9.1%9.7%
Operating margin1.7%4.2%4.6%3.7%3.7%5.6%6.2%6.0%-2.8%1.7%
Net margin1.0%2.9%3.2%2.5%2.4%3.5%4.4%3.7%-2.6%0.3%
Free cash flow margin-1.4%1.3%4.6%2.1%7.4%9.4%2.2%-1.8%3.6%2.8%
Return on equity11.6%26.2%25.9%26.7%25.1%32.1%37.6%42.9%-38.3%3.2%
Return on assets3.0%7.5%7.3%6.4%5.4%7.1%10.9%9.9%-6.0%0.7%
Current ratio1.691.621.541.471.431.591.831.521.351.31
Debt to equity0.930.650.520.730.831.010.640.620.990.88

Source: XBRL data Molina Healthcare Inc files with the SEC, latest filing dated Oct 22, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

MOH peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
MOH$44.13B-0.9%-$48.00M-0.1%$10.61B
UNH$449.66B+3.3%$15.88B3.5%$356.28B
ELV$201.83B+3.6%$5.13B2.5%$90.37B
CI$286.32B+6.8%$5.99B2.1%$77.89B
HUM$154.19B+22.0%$1.25B0.8%$50.82B
NTRA$2.91B+37.4%-$164.71M-5.7%$46.46B
CNC$203.90B+9.7%$1.46B0.7%$33.93B
ILMN$4.54B+5.8%$895.00M19.7%$33.38B
LH$14.59B+6.0%$1.00B6.9%$30.19B

MOH FAQ

8 questions
  • What is MOH revenue?
    Molina Healthcare Inc (MOH) reported $44.13B of revenue for the twelve months ended Sep 30, 2026. That is down 0.9% from the year before. Revenue for fiscal 2025 was $45.43B.
  • Is MOH profitable?
    No. Molina Healthcare Inc reported a net loss of $48.00M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does MOH have?
    Molina Healthcare Inc reported $4.48B in cash and cash equivalents and $3.77B of debt on its most recent balance sheet in SEC filings.
  • How fast is MOH revenue growing?
    Molina Healthcare Inc's revenue changed +11.7% in fiscal 2025, to $45.43B. Its compound annual growth rate was +18.5% over 5 years and +12.3% over 10 years.
  • What is MOH free cash flow?
    Molina Healthcare Inc generated $236.00M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $331.00M less capital expenditures.
  • What is MOH earnings per share?
    Diluted earnings per share were -$0.60 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did MOH last report financial results?
    The latest statements here come from Molina Healthcare Inc's 10-Q filed on Oct 22, 2026, covering the period ended Sep 30, 2026.
  • Where does this MOH financial data come from?
    Quantisnow builds these statements from the structured XBRL data Molina Healthcare Inc files with the SEC. It is provided for information only and is not investment advice.